A vs ABT: Which Stock is Better?

Side-by-side comparison of Agilent Technologies Inc and Abbott Laboratories in 2026

Comparison Updated:

A

Agilent Technologies Inc

$117.50

ABT

Abbott Laboratories

$100.65

Key Metrics Comparison

MetricAABTWinner
Market Cap$32.54B$174.29BABT
P/E Ratio25.4026.96A
EPS (TTM)$4.53$3.72A
Revenue Growth0.1%0.0%A
Gross Margin52.3%56.7%ABT

Analyze A

Full quant analysis

Analyze ABT

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is A or ABT a better investment?

Comparing A and ABT: Agilent Technologies Inc has a market cap of $32.54B while Abbott Laboratories has $174.29B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between A and ABT?

A (Agilent Technologies Inc) and ABT (Abbott Laboratories) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: A or ABT?

Based on P/E ratios, A trades at a lower multiple (25.4x vs 27.0x).

Which is growing faster: A or ABT?

A has higher revenue growth at 0.1% vs 0.0% for ABT.

Which company is more profitable: A or ABT?

Abbott Laboratories (ABT) has higher gross margins at 56.7% compared to 52.3% for A.

Which is the larger company: A or ABT?

Abbott Laboratories (ABT) is larger with a market cap of $174.29B compared to $32.54B for A.

Should I buy A or ABT in 2026?

Both A and ABT have investment merit. A trades at $117.50 while ABT trades at $100.65. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between A and ABT stock?

Key differences: Market Cap ($32.54B vs $174.29B), P/E Ratio (25.4x vs 27.0x), Revenue Growth (0.1% vs 0.0%), Gross Margin (52.3% vs 56.7%).

Popular Stock Comparisons